Creatine is one of the most studied compounds in sports nutrition. The basic mechanism has been understood for decades: taken as a supplement, creatine increases phosphocreatine stores in skeletal muscle, which supports the rapid regeneration of adenosine triphosphate during short bursts of high-intensity activity. More reps, heavier lifts, faster sprint recovery. The research base underpinning those benefits is substantial and not seriously contested.
What is changing in 2026 is not the science. It is the supply chain, the format landscape, and a growing consumer-level debate about product quality that played out publicly on social media before it reached the trade show floor.
The Market
Creatine monohydrate accounted for 68.6% of the creatine supplement market in 2025. Powder was the dominant delivery format at 78.57% of total market volume. Both figures reflect the same reality: creatine monohydrate in powder form is what the evidence supports, what athletes and coaches recommend, and what most consumers who take creatine actually use.
The market is not standing still, though. Demand is expanding beyond the traditional gym and performance audience into cognitive health, women's health, and healthy aging. Creatine is present in the brain as well as in skeletal muscle, and a growing research pipeline covers its potential role in memory, mood, and processing speed, particularly in older adults and populations with lower baseline creatine levels. Researchers are also exploring its potential in conditions including Parkinson's disease, depression, and menopause-related muscle and bone loss, though that research is at an earlier stage.
The Supply Concentration Problem
For many years, the B2B market for premium creatine monohydrate has been concentrated with a single supplier. AlzChem AG, headquartered in Germany, manufactures Creapure at its facility in Trostberg, Bavaria. Creapure is produced under pharmaceutical GMP standards and tested for DCD (dicyandiamide), DHT (dihydrotriazine), and thiourea, three contaminants associated with lower-grade creatine production, the majority of which is manufactured in China. Over 110 verified brands use Creapure as their creatine source.
AlzChem is not standing still either. In December 2025, the company announced a €120 million investment in its creatine value chain, citing its strong position in the premium segment and long-term growth potential in new application areas. It also extended its title partnership with HYROX, the international fitness event series, for the 2025/2026 season, and through its Creavitalis brand is actively positioning creatine for health-market applications including women's health, cognitive performance, and longevity.
The concentration argument was taken directly to Vitafoods Europe 2026 in Barcelona by a Netherlands-based challenger brand. Qura Creatine, co-founded by Michael Hekking and Erik van Velsen, officially launched at the show in Hall 6 and the New Ingredients Zone in May 2026. Hekking, who spent nine years as co-founder and CEO of caffeinated chewing gum brand FIRST Energy Gum, said his decision to launch Qura came from his experience sourcing creatine for a product extension. "When I looked into creating the creatine tablets, I discovered the near-monopoly for high quality creatine," he said. "With demand rocketing and consumers crying out for innovative new products, it's unsustainable for the market to remain this way."
Qura claims purity above 99.95%, independently verified, with each batch traceable and tested in both the EU and US for safety, anti-doping assurance, and regulatory compliance. The company says it has engineered its product for superior solubility and rapid dispersion, and has eliminated grit and bitter aftertaste common in standard monohydrate powders. Its internal testing compared dispersion speed against a leading premium creatine, though those results have not been independently published.
What the launch represents is the first credible challenger to build a public-facing case specifically around the supply concentration argument in the European market.
Format Innovation and the Gummy Problem
Powder dominates but the pressure toward new formats is real. Gummies, RTDs, sachets, and functional food formats have expanded as brands work to reach consumers who find a daily powder scoop inconvenient or unappealing. The format expansion also reflects the category's move into new demographics: the everyday wellness consumer is a different buyer to the gym regular.
The gummy format arrived with a documented quality problem. NOW Foods tested 12 creatine gummy brands using HPLC and found six failed to meet their label claims. Several failing products also showed significant levels of creatinine, a degradation byproduct that forms when creatine is exposed to water during manufacturing. Creatine is stable in powder form but converts to creatinine in water-based systems, which is how gummies are made. NOW noted it was unable to find a third-party lab capable of accurately testing gummies, a finding that pointed to quality assurance infrastructure lagging behind the format's commercial growth.
The issue reached mainstream audiences through social media. British influencer James Smith published testing results showing four of nine creatine gummy brands he tested contained inadequate levels of creatine. The videos circulated widely across fitness communities. The controversy extended to the brand Push Creatine Monohydrate Gummies: following Smith's testing, Push confirmed internally that some batches had fallen short of label claims and said it believed its former manufacturer had altered the product formula without the brand's knowledge, sending different, fully-dosed samples to Eurofins for quality certification. Push took its product off sale and announced a new manufacturing partner.
Smith subsequently launched his own creatine product in sachet format using Creapure, citing his inability to find sufficient published literature confirming creatine stability in gummies.
The engineering response to the format problem was visible at Vitafoods 2026. MCB Group's CreHytine, named a Vitafoods Innovation Award finalist in the Sports Nutrition and Active Lifestyle Ingredient category, uses hydrogel and buffered technology at pH 9-11 to achieve 100% water solubility, specifically designed to address the stability and solubility issues that characterise standard creatine in water-based formats. Whether the technology fully resolves the gummy stability challenge has not been published in peer-reviewed literature.
Beyond Performance
The non-performance applications of creatine were visible across Vitafoods 2026. AlzChem's corporate communications lead described women's health, cognitive performance, healthy aging, and longevity as an "extremely exciting and forward-looking field" for its Creavitalis health-market brand. Balchem's VP of Science and Marketing Dominik Mattern noted on the show floor that social media trends have driven creatine into new health applications across demographics beyond the traditional sports nutrition consumer.
At the brand level, ESN launched peach-flavoured Ultrapure Creatine Gummies and Crank, a 3-in-1 pre-workout, while Bulletproof launched Coffee + Creatine, a functional coffee product combining creatine and electrolytes for performance and cognitive support. Both launches reflect the same dynamic: creatine moving into everyday consumption occasions and formats, rather than sitting solely in the pre- or post-workout window.
The clinical research pipeline is also broadening. In October 2023, AlzChem in collaboration with Crearene AG launched a clinical study to explore creatine's potential role in dialysis treatment, evaluating feasibility, dosage, and patient safety for creatine-based dialysis solutions.
What the Category Requires Now
The brands that navigated the gummy quality controversy without damage were those with third-party testing documentation in place before the scrutiny arrived. Bear Balanced, the brand that launched the first commercially available creatine gummy in 2022 using Creapure, tested 165mg above its 1,000mg per gummy label claim in NOW's testing. Its founder attributed that result to the difficulty of the formulation and the testing infrastructure built around it.
For brands building in the creatine category now, the traceability and testing question is not an optional extra. Independent testing, batch-level documentation, and format-specific stability validation are what separates products that can withstand public scrutiny from those that cannot.
Sources: NutraIngredients, Nutraceutical Business Review, Nutrition Insight, Food and Drink Technology, Vitafoods Insights, Nutraceuticals World, Nutritional Outlook, Gymfluencers, Legion Athletics, SuppCo, ScienceDaily, PMC/NIH, AlzChem AG, Fundamental Business Insights.